You are here: Industry Insights > virus

News List

WHO supports containment of rare virus on Uganda-Kenya border biospectrumasia
October 24, 2017
Marburg virus disease is a rare disease with a high mortality rate for which there is no specific treatment
SWINE FLU raises its ugly head again in India biospectrumasia
September 06, 2017
The pandemic stain is no longer referred as “swine flu”, its correct nomenclature is A(H1N1)pdm09 virus. Since 2009 this virus was antigenically similar to A/California/07/2009 which was recommended vaccine component from 2009 to 2016.
Influenza virus mutations prevented during vaccine production europeanpharmaceuticalreview
July 26, 2017
Duke researchers used a bivalent virus from chicken cells that packaged twice as much protein as a monovalent virus, and vaccinated mice with either the bivalent or monovalent vaccine
Virus study targets infection linked to birth defects BioSpace.com
May 18, 2017
Fresh insights into how a common virus replicates could pave the way for new therapies to stop its spread
Frog mucus may offer protection against flu virus pharmafile
April 20, 2017
Fairy tales about kissing frogs may have been onto something after all, maybe not to acquire a prince but possibl...
Virus fixes DNA mutations for possible hearing loss therapy pharmafile
April 11, 2017
Researchers at the Medical School at Harvard and MedUni Vienna’s Department of Ear, Nose and Throat Diseases have ...
New Hepatitis C Drugs Might Eliminate the Disease drugs.com
March 21, 2017
Newer treatments for hepatitis C appear to eliminate the virus in the vast majority of those taking oral antiviral medications, raising the hope that this disease might someday be eradicated in the United States.
MedImmune and Sanofi Pasteur form alliance to develop and commercialise potential next-generation re worldpharmanews
March 08, 2017
MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, have announced an agreement to develop and commercialise MEDI8897 jointly.
Novavax hopes to revive RSV vaccine with a new phase 2 trial fiercepharma
January 25, 2017
Novavax has started a new phase 2 trial on its key respiratory syncytial virus vaccine candidate in an effort to breathe new life into a program that was hit hard last fall with disheartening late stage data.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page